Literature DB >> 19593575

[MMP- and FAP-mediated non-inflammation-related destruction of cartilage and bone in rheumatoid arthritis].

M Jakobs1, T Häupl, V Krenn, R Guenther.   

Abstract

INTRODUCTION: Due to morphological similarities of high-grade synovitis in rheumatoid Arthritis (RA) and mesenchymal, semimalignant tumors and the hypothesis that RA progression is not only inflammation-related, but also determined by tumor-like mechanisms, a comparison was made between expression profiles of RA, giant cell tumor of bone (GCT) and normal synovium (ND).
METHODS: Array data of selected genes were validated through immunohistochemical staining of paraffin-embedded and deep frozen tissue samples of GCT, RA and normal synovium.
RESULTS: With microarray analysis, CCR1, CCR5, MMP-1, MMP-2, MMP-3, MMP-9, MMP-14 and FAP were found to be significantly upregulated in RA and GCT compared to ND. A significant upregulation in RA and GCT compared to ND could be validated by immunohistochemistry for MMP-1, MMP-9, MMP-14 and FAP. DISCUSSION: For MMPs, and MMP-9 in particular, an important role in early cartilage destruction of RA was suggested. The presence of FAP in RA and in stroma of a semimalignant tumor indicates tumor-like tissue destruction in chronic synovitis associated with RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19593575     DOI: 10.1007/s00393-009-0461-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  29 in total

1.  MAP kinase activation is required for the MMP-9 induction by TNF-stimulation.

Authors:  Kyung Chan Kim; Chu Hee Lee
Journal:  Arch Pharm Res       Date:  2005-11       Impact factor: 4.946

2.  Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.

Authors:  Raphaela Guenther; Veit Krenn; Lars Morawietz; Anja Dankof; Ingo Melcher; Klaus-Dieter Schaser; Hans-Udo Kasper; Ralf-Jürgen Kuban; Ute Ungethüm; Christine Sers
Journal:  Pathol Res Pract       Date:  2005-09-26       Impact factor: 3.250

3.  Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.

Authors:  Jaewoo Lee; Martin Fassnacht; Smita Nair; David Boczkowski; Eli Gilboa
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 4.  [Expression analyses for rheumatoid arthritis].

Authors:  R Guenther; V Krenn; T Häupl
Journal:  Z Rheumatol       Date:  2008-02       Impact factor: 1.372

5.  Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches.

Authors:  Katharina Finis; Holger Sültmann; Markus Ruschhaupt; Andreas Buness; Birgit Helmchen; Ruprecht Kuner; Marie-Luise Gross; Bernd Fink; Peter Schirmacher; Annemarie Poustka; Irina Berger
Journal:  Arthritis Rheum       Date:  2006-03

6.  Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis.

Authors:  Jungsu Hwang; Kyung-No Son; Chan Woo Kim; Jesang Ko; Doe Sun Na; Byoung S Kwon; Yong Song Gho; Jiyoung Kim
Journal:  Cytokine       Date:  2005-03-24       Impact factor: 3.861

7.  Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha.

Authors:  Kathleen Aertgeerts; Irena Levin; Lihong Shi; Gyorgy P Snell; Andy Jennings; G Sridhar Prasad; Yanming Zhang; Michelle L Kraus; Shant Salakian; Vandana Sridhar; Robert Wijnands; Mike G Tennant
Journal:  J Biol Chem       Date:  2005-04-04       Impact factor: 5.157

Review 8.  The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

Authors:  Hiroyuki Takahashi; Masabumi Shibuya
Journal:  Clin Sci (Lond)       Date:  2005-09       Impact factor: 6.124

Review 9.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

Review 10.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  1 in total

1.  Comparative Studies of Different Extracts from Eucommia ulmoides Oliv. against Rheumatoid Arthritis in CIA Rats.

Authors:  Jian-Ying Wang; Xiao-Jun Chen; Lei Zhang; Ying-Yi Pan; Zu-Xi Gu; Shi-Min He; Zhe-Ping Song; Ying Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-11       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.